Baghdad-based scientific bureau
Global science.
Delivered with care.
We connect trusted pharmaceutical innovation with Iraq's healthcare network - protecting product integrity, accelerating access, and keeping patients at the center of every decision.
GDPGuided operations
From regulatory clearance to the last mile.
Who we are
The last mile is where our work becomes human.
Scientific approval is only the first hurdle. A medicine creates value when it reaches the right patient safely, efficiently, and with its integrity intact.
Al Taif Al Dawa'i Scientific Bureau was founded to bridge the gap between regulatory clearance and real-world access. We combine local market knowledge, disciplined logistics, and long-term manufacturer relationships to build reliable pathways across Iraq's complex healthcare ecosystem.
Our core team brings deep pharmaceutical and medical-supply experience, supported by a practical understanding of the Ministry of Health, hospitals, pharmacies, and local care networks.
Our vision
To become the region's most trusted guardian of patient safety and pharmaceutical integrity.
Our mission
To make high-quality therapies accessible through ethical partnerships, resilient distribution, and transparent service.
What we do
A connected system for safe, dependable access.
Every capability supports one shared outcome: moving essential healthcare products from trusted manufacturers to the people who need them.
Strategic Distribution
Tailored channels informed by healthcare infrastructure, demand, and patient access.
GDP & Cold Chain
Temperature-aware handling and controlled operations designed to preserve potency.
MOH Tenders
Contract coordination and follow-through aligned with Iraqi Ministry of Health standards.
Local Market Access
Responsive coverage across 15 provinces for public, private, and urgent hospital demand.
Technical Support
Qualified professionals supporting medical and laboratory devices in key Iraqi cities.
Pharmacovigilance
A dedicated safety channel for responsible reporting and ongoing product oversight.
Operational focusIntegrity at every handoff
Built for reliability
A warehouse is more than storage. It is a promise.
Our operating model is designed around quality release, product traceability, and controlled stock movement - protecting therapies before they travel the final mile.
- 1Quarantine control
Segregated incoming goods remain controlled until quality release.
- 2Temperature mapping
GDP-aligned environments support dependable product conditions.
- 3FEFO / FIFO rotation
Disciplined inventory movement prioritizes expiry and product integrity.
- 4Fire protection
Integrated safety systems support a secure operational environment.
Experience & excellence
Strong systems work because committed people make them work.
Our team combines academic credentials, regional knowledge, and practical healthcare experience.
International portfolio
Trusted science has no borders.
We collaborate with reputable manufacturers to bring specialist therapies and dependable healthcare products to the Iraqi market.
Switzerland
Lagap S.A.
Marketing authorization and pharmaceutical portfolio partnership.
Ukraine
Biopharma Plasma LLC
A broad portfolio of immunoglobulin products.
Germany
AMW GmbH
Biodegradable slow-release and transdermal formulations.
India
Venus Remedies Limited
Specialized oncology products and antibiotics.
United States
Boston Biopharma
High-quality specialty medications for global markets.
India
Shree Anand Life Sciences
Development and manufacturing across a wide range of therapeutic areas.
Our journey
Built deliberately. Growing responsibly.
Each phase strengthened the next - from market understanding to authorized distribution.
Research & planning
Building a strong foundation around Iraqi market needs.
Promotion & activation
Supporting early orders to healthcare institutions.
Monitoring & evaluation
Strengthening product follow-up with specialist oversight.
Authorized distributor
Representing a portfolio of reputable international companies.
Patient safety and adverse event reporting
Pharmacovigilance.
Every report matters.
What is ADR?
An adverse drug reaction (ADR) is a harmful and unintended response to a medicine used at normal doses for prevention, diagnosis, treatment, or modification of a physiological function.
What should be reported?
Report any suspected adverse event or side effect, whether known or unknown, including:
- Overdose, abuse, misuse, or off-label use
- Exposure during pregnancy or breastfeeding
- Medication errors, interactions, or occupational exposure
- Damaged, discoloured, misshaped, or tampered product packaging
- Any other product quality-related complaint
Serious reactions
A reaction is considered serious when the patient outcome includes:
- Death or a life-threatening event
- Initial or prolonged hospitalization
- Significant, persistent, or permanent disability
- Congenital anomaly
- Intervention required to prevent permanent impairment or damage
Who can report an ADR / AE?
- Any healthcare professional: doctors, clinicians, dentists, pharmacists, nurses, and other healthcare professionals.
- Non-healthcare professionals: patients, relatives, friends, or anyone with sufficient knowledge of the adverse event.
Start a conversation
Better access begins with the right connection.
For partnerships, product safety, or commercial enquiries, speak directly with the relevant member of our team.
Message us on WhatsApp
DirectorDirector.pharma@survi-medicine.com
Business developmentDr.Mohammed.Sadiq@survi-medicine.com
CEOmoamar@spectrum-medlab.com
Sales Manager+964 780 922 2451
Headquarters
Al Sadoon Street, Hay Al BataweenLocality 101, House No. 33
Baghdad, Iraq